Skye Bioscience, Inc. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
Skye Bioscience, Inc. (SKYE) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of -$42.33 thousand for the 9-month period ending 2018-09-30, per its 10-Q filed 2018-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2018-11-14
- Skye Bioscience, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2018-09-30 was $40.97K.
- Skye Bioscience, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2018-06-30 was -$17.71K.
- Skye Bioscience, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2018-03-31 was -$65.59K, a 125.92% decline year-over-year.
- Skye Bioscience, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2017-12-31 was $28.34K.
- Skye Bioscience, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2017 was $42.68K.
- Skye Bioscience, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2016 was -$130.73K, a 225.13% decline from fiscal 2015.
- Skye Bioscience, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2015 was $104.47K, a 120.39% increase from fiscal 2014.
- Skye Bioscience, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2014 was $47.40K, a 60.63% decline from fiscal 2013.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2018-09-30 | $40.97K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $23.26K derived: sum of 2 quarters · filed 2018-11-14 | -$42.33K 10-Q · filed 2018-11-14 | -$14.00K derived: sum of 4 quarters · filed 2018-11-14 |
| 2018-06-30 | -$17.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | -$83.30K 10-Q · filed 2018-08-10 | -$54.97K derived: sum of 3 quarters · filed 2018-08-10 | -$141.40K derived: sum of 4 quarters · filed 2018-11-14 |
| 2018-03-31 | -$65.59K 10-Q · filed 2018-05-15 | -$37.25K derived: sum of 2 quarters · filed 2018-05-15 | -$123.69K derived: sum of 3 quarters · filed 2018-11-14 | -$275.95K derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-12-31 | $28.34K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19 | -$58.10K derived: sum of 2 quarters · filed 2018-11-14 | -$210.37K derived: sum of 3 quarters · filed 2018-11-14 | $42.68K 10-K · filed 2018-03-19 |
| 2017-09-30 | -$86.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$238.70K derived: sum of 2 quarters · filed 2018-11-14 | $14.34K 10-Q · filed 2018-11-14 | -$19.89K derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | -$152.26K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $100.78K 10-Q · filed 2018-08-10 | $66.55K derived: sum of 3 quarters · filed 2018-08-10 | $31.13K derived: sum of 4 quarters · filed 2018-08-10 |
| 2017-03-31 | $253.04K 10-Q · filed 2018-05-15 | $218.81K derived: sum of 2 quarters · filed 2018-05-15 | $183.40K derived: sum of 3 quarters · filed 2018-05-15 | $194.52K derived: sum of 4 quarters · filed 2018-05-15 |
| 2016-12-31 | -$34.23K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19 | -$69.64K derived: sum of 2 quarters · filed 2018-03-19 | -$58.52K derived: sum of 3 quarters · filed 2018-03-19 | -$130.73K 10-K · filed 2018-03-19 |
| 2016-09-30 | -$35.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | -$24.29K derived: sum of 2 quarters · filed 2017-11-14 | -$96.50K 10-Q · filed 2017-11-14 | -$44.92K derived: sum of 4 quarters · filed 2017-11-14 |
| 2016-06-30 | $11.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | -$61.08K 10-Q · filed 2017-08-11 | -$9.51K derived: sum of 3 quarters · filed 2017-08-11 | $110.27K derived: sum of 4 quarters · filed 2017-08-11 |
| 2016-03-31 | -$72.21K 10-Q · filed 2017-05-12 | -$20.63K derived: sum of 2 quarters · filed 2017-05-12 | $99.14K derived: sum of 3 quarters · filed 2017-05-12 | -$401.00 derived: sum of 4 quarters · filed 2017-05-12 |
| 2015-12-31 | $51.58K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $171.35K derived: sum of 2 quarters · filed 2017-03-10 | $71.81K derived: sum of 3 quarters · filed 2017-03-10 | $104.47K 10-K · filed 2017-03-10 |
| 2015-09-30 | $119.78K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $20.23K derived: sum of 2 quarters · filed 2016-11-09 | $52.90K 10-Q · filed 2016-11-09 | -$67.05K derived: sum of 4 quarters · filed 2016-11-09 |
| 2015-06-30 | -$99.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | -$66.88K 10-Q · filed 2016-08-12 | -$186.83K derived: sum of 3 quarters · filed 2016-08-12 | $152.96K derived: sum of 4 quarters · filed 2016-08-12 |
| 2015-03-31 | $32.67K 10-Q · filed 2016-05-13 | -$87.28K derived: sum of 2 quarters · filed 2016-05-13 | $252.51K derived: sum of 3 quarters · filed 2016-05-13 | $49.97K derived: sum of 4 quarters · filed 2016-05-13 |
| 2014-12-31 | -$119.95K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-21 | $219.84K derived: sum of 2 quarters · filed 2016-03-21 | $17.30K derived: sum of 3 quarters · filed 2016-03-21 | $47.40K 10-K · filed 2016-03-21 |
| 2014-09-30 | $339.79K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $137.25K derived: sum of 2 quarters · filed 2015-11-12 | $167.35K 10-Q · filed 2015-11-12 | |
| 2014-06-30 | -$202.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | -$172.44K 10-Q · filed 2015-08-14 | ||
| 2014-03-31 | $30.10K 10-Q · filed 2015-05-13 | |||
| 2013-12-31 | $120.40K 10-K · filed 2015-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |